Patents by Inventor Arie Admon

Arie Admon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers for cancer detection
    Patent number: 8741581
    Abstract: The present invention relates to methods for detecting, prognosing and staging cancers, in particular cancers of the gastrointestinal tract. The methods of the invention comprise detecting specific protein markers in a tissue of interest, wherein the detected levels thereof may be indicative of pre-cancerous or cancerous tissue, or the stage or prognosis of a cancer. Further provided are methods of treating cancer, and cancer detection kits.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: June 3, 2014
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Arie Admon, Eilon Barnea, Ilan Beer, Tamar Ziv
  • SOLUBLE HLA COMPLEXES FOR USE IN DISEASE DIAGNOSIS
    Publication number: 20120077696
    Abstract: The invention relates to diagnostic kits, methods of diagnosing, prognosing and staging diseases, and immunogenic compositions. The invention is based on the detection of peptides associated with circulating soluble HLA complexes in particular disease states, including malignant diseases.
    Type: Application
    Filed: March 14, 2010
    Publication date: March 29, 2012
    Applicant: Technion Research and Development Foundation Ltd.
    Inventors: Arie Admon, Michal Bassani-Sternberg
  • MARKERS FOR CANCER DETECTION
    Publication number: 20120039811
    Abstract: The present invention relates to methods for detecting, prognosing and staging cancers, in particular cancers of the gastrointestinal tract. The methods of the invention comprise detecting specific protein markers in a tissue of interest, wherein the detected levels thereof may be indicative of pre-cancerous or cancerous tissue, or the stage or prognosis of a cancer. Further provided are methods of treating cancer, and cancer detection kits.
    Type: Application
    Filed: April 27, 2010
    Publication date: February 16, 2012
    Applicant: Technion Research And Development Foundation LTD.
    Inventors: Arie Admon, Eilon Barnea, Ilan Beer, Tamar Ziv
  • Placental protein 13
    Patent number: 7211405
    Abstract: The full amino acid and DNA sequences of placental protein 13 (PP13) are disclosed. Also described are various PP13 derived peptide fragments, and a recombinant method for the production of PP13. PP13 may be used in a screening and a diagnostic method for pregnancy-related complications.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: May 1, 2007
    Assignee: Diagnostic Technologies Ltd.
    Inventors: Arie Admon, Yoav Paltieli, Ronit Slotky, Silvia Mandel
  • Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells
    Patent number: 6867283
    Abstract: A method of identifying peptides originating from a particular cell type and being capable of binding to MHC molecules of a particular haplotype is disclosed. The method comprises obtaining a cell type expressing a soluble and secreted form of the MHC molecules of the particular haplotype; collecting the soluble and secreted form of the MHC molecules of the particular haplotype; and analyzing peptides bound to the soluble and secreted form of the MHC molecules of the particular haplotype, thereby identifying the peptides originating from the particular cell type and being capable of binding to MHC molecules of the particular haplotype.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: March 15, 2005
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Eilon Barnea, Ilan Beer, Tamar Ziv, Arie Admon
  • Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
    Publication number: 20050053918
    Abstract: A method of identifying peptides originating from a particular cell type and being capable of binding to MHC molecules of a particular haplotype is disclosed. The method comprises obtaining a cell type expressing a soluble and secreted form of the MHC molecules of the particular haplotype; collecting the soluble and secreted form of the MHC molecules of the particular haplotype; and analyzing peptides bound to the soluble and secreted form of the MHC molecules of the particular haplotype, thereby identifying the peptides originating from the particular cell type and being capable of binding to MHC molecules of the particular haplotype.
    Type: Application
    Filed: November 12, 2003
    Publication date: March 10, 2005
    Inventors: Eilon Barnea, Ilan Beer, Tamar Ziv, Arie Admon, Lior Dassau, Samuel Buchsbaum
  • Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
    Publication number: 20030096298
    Abstract: A method of identifying peptides originating from a particular cell type and being capable of binding to MHC molecules of a particular haplotype is disclosed. The method comprises obtaining a cell type expressing a soluble and secreted form of the MHC molecules of the particular haplotype; collecting the soluble and secreted form of the MHC molecules of the particular haplotype; and analyzing peptides bound to the soluble and secreted form of the MHC molecules of the particular haplotype, thereby identifying the peptides originating from the particular cell type and being capable of binding to MHC molecules of the particular haplotype.
    Type: Application
    Filed: May 29, 2001
    Publication date: May 22, 2003
    Inventors: Eilon Barnea, Ilan Beer, Tamar Ziv, Arie Admon
  • Placental protein 13
    Publication number: 20030092188
    Abstract: The full amino acid and DNA sequences of placental protein 13 (PP13) are disclosed. Also described are various PP13 derived peptide fragments, and a recombinant method for the production of PP13. PP13 may be used in a screening and a diagnostic method for pregnancy-related complications.
    Type: Application
    Filed: November 5, 2002
    Publication date: May 15, 2003
    Applicant: DIAGNOSTIC TECHNOLOGIES LTD.
    Inventors: Arie Admon, Yoav Paltieli, Ronit Slotky, Silvia Mandeli
  • Placental protein 13
    Patent number: 6548306
    Abstract: The full amino acid and DNA sequences of placental protein 13 (PP13) are disclosed. Also described are various PP13 derived peptide fragments, and a recombinant method for the production of PP13. PP13 may be used in a screening and a diagnostic method for pregnancy-related complications.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: April 15, 2003
    Assignee: Diagnostic Technologies Ltd.
    Inventors: Arie Admon, Yoav Paltieli, Ronit Slotky, Silvia Mandel